Literature DB >> 4075590

Assessment of delayed-type hypersensitivity in man: a comparison of the "Multitest" and conventional intradermal injection of six antigens.

I H Frazer, E J Collins, J S Fox, B Jones, R C Oliphant, I R Mackay.   

Abstract

Recall of delayed type hypersensitivity (DTH) as a test for cell-mediated immune competence was assessed in 254 subjects using the Multitest device which delivers seven skin-test antigens intradermally; 77 subjects were tested concurrently by Multitest and a conventional panel of six antigens. Similar results were obtained with Multitest and the conventional panel (R = 0.65). Reproducibility of Multitest between three observers, who independently assessed the aggregate size of reactions (the reaction score) in 45 subjects, was high (R = 0.89). Twenty-four subjects were tested twice 3 months apart; the correlation for the reaction score was high (R = 0.88), demonstrating the suitability of Multitest for serial studies of immune function. Anergy was infrequent (1%) among 110 healthy male controls but was more frequent (8%) among a group of 101 healthy male homosexuals (P less than 0.05). The response rate to particular test antigens differed for the three Australian groups tested and a previously studied French group. Hence there is a need to establish normal profiles of DTH responsiveness for different geographic areas, as well as among subjects of known age and sex, when assessing cell-mediated immunity by the level of DTH responsiveness to multiple skin test antigens.

Entities:  

Mesh:

Year:  1985        PMID: 4075590     DOI: 10.1016/0090-1229(85)90064-9

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  2 in total

1.  Anergy compromises screening for tuberculosis in high-risk populations.

Authors:  S R Zoloth; S Safyer; J Rosen; D Michaels; P Alcabes; E Bellin; C Braslow
Journal:  Am J Public Health       Date:  1993-05       Impact factor: 9.308

2.  Abnormal chest x-rays in intravenous drug users: implications for tuberculosis screening programs.

Authors:  E Bellin; D Fletcher; S Safyer
Journal:  Am J Public Health       Date:  1993-05       Impact factor: 9.308

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.